Diferencia entre revisiones de «Midazolam»
(Text replacement - "alpha" to "α") |
(Switch SMW query from broadtable to table format for better layout with TOC) |
||
| (No se muestran 21 ediciones intermedias de 6 usuarios) | |||
| Línea 1: | Línea 1: | ||
''See [[critical care quick reference]] for drug doses by weight.'' | ''See [[critical care quick reference]] for drug doses by weight.'' | ||
==General== | ==General== | ||
*Type: [[Benzodiazepines]] | *Type: [[Is DrugClass::Benzodiazepines]] | ||
*Dosage Forms: IV | *Dosage Forms: IV | ||
*Common Trade Names: Versed | *Common Trade Names: [[BrandName::Versed]] | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Anxiolysis/sedation: | *[[Has Indication::Anxiolysis]]/[[Has Indication::sedation]]: | ||
**1-2mg IV push | **1-2mg IV push | ||
**0.07 to 0.08 mg/kg IM, usual dose 5 mg for 60 kg pt | **0.07 to 0.08 mg/kg IM, usual dose 5 mg for 60 kg pt | ||
*[[Seizure]]: | |||
**[[SeizureDose::10mg IM/IV]] | |||
*ICU Sedation: | *ICU Sedation: | ||
**Load: 10-50mcg/kg IV infusion | **Load: 10-50mcg/kg IV infusion | ||
| Línea 21: | Línea 23: | ||
*Intranasal | *Intranasal | ||
**Seizure: 0.2 mg/kg IN divided between nostrils | **[[Has Indication::Seizure]]: 0.2 mg/kg IN divided between nostrils | ||
**Procedural sedation: 0.2-0.6 mg/kg IN divided between nostrils | **Procedural sedation: 0.2-0.6 mg/kg IN divided between nostrils | ||
**Anxiolysis: 0.5 mg/kg IN (max dose 10 mg) | |||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: D | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: D | ||
| Línea 43: | Línea 46: | ||
*Hypopnea | *Hypopnea | ||
*Hypotension | *Hypotension | ||
*Delirium, when used for prolonged periods in ICU setting | *[[Delirium]], when used for prolonged periods in ICU setting | ||
===Common=== | ===Common=== | ||
*Drowsiness | *Drowsiness | ||
*Nausea/vomiting | *[[Nausea/vomiting]] | ||
==Pharmacology== | ==Pharmacology== | ||
*Peak effect: | *Peak effect: | ||
| Línea 53: | Línea 57: | ||
**Intranasal: 10 minutes | **Intranasal: 10 minutes | ||
*Duration | *Duration | ||
**IV: Single dose: <2 hours (dose-dependent),up to 6 hours | **IV: Single dose: <2 hours (dose-dependent),up to 6 hours with cirrhosis | ||
**IM: Up to 6 hours; Mean: 2 hours | **IM: Up to 6 hours; Mean: 2 hours | ||
**Intranasal: Children: 18 to 41 minutes | **Intranasal: Children: 18 to 41 minutes | ||
*Half-life: 1.8-6.4 hr | *Half-life: 1.8-6.4 hr | ||
*Metabolism: Metabolized in liver by CYP3A4 to active metabolite | *Metabolism: Metabolized in liver by CYP3A4 to active metabolite α<sub>1</sub>-hydroxymidazolam | ||
*Excretion: Renal | *Excretion: Renal | ||
*Mechanism of Action: CNS depressant. Acts at GABA receptor to increase frequency of chloride channel opening, causing hyperpolarization and stabilization of neuronal membrane. | *Mechanism of Action: CNS depressant. Acts at GABA receptor to increase frequency of chloride channel opening, causing hyperpolarization and stabilization of neuronal membrane. | ||
==Indications by Condition== | |||
''The following table is automatically generated from disease/condition pages across WikEM.'' | |||
{{#ask:[[Has DrugName::Midazolam]] | |||
|?Has Indication=Indication | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|?Has Route=Route | |||
|?Has Population=Population | |||
|format=table | |||
|headers=plain | |||
|mainlabel=- | |||
|sort=Has Indication | |||
|limit=50 | |||
}} | |||
==See Also== | ==See Also== | ||
Revisión actual - 21:56 20 mar 2026
See critical care quick reference for drug doses by weight.
General
- Type: Benzodiazepines
- Dosage Forms: IV
- Common Trade Names: Versed
Adult Dosing
- Anxiolysis/sedation:
- 1-2mg IV push
- 0.07 to 0.08 mg/kg IM, usual dose 5 mg for 60 kg pt
- Seizure:
- 10mg IM/IV
- ICU Sedation:
- Load: 10-50mcg/kg IV infusion
- Maintenance: 20-100 mcg/kg/hr infusion
- Use with standardized sedation protocol for titration
Pediatric Dosing
See critical care quick reference for drug doses by weight.
- Anxiolysis/sedation:
- 6mo-5yr: 0.05-0.1 mg/kg IV push
- 6-12yr: 0.025-0.05 mg/kg IV push
- Intranasal
- Seizure: 0.2 mg/kg IN divided between nostrils
- Procedural sedation: 0.2-0.6 mg/kg IN divided between nostrils
- Anxiolysis: 0.5 mg/kg IN (max dose 10 mg)
Special Populations
- Pregnancy Rating: D
- Maternal use shortly before delivery associated with floppy infant syndrome
- Lactation: Distributed in breast milk, use with caution
- Renal Dosing:
- Adult: Decrease by 50% for severe renal failure
- Pediatric
- Hepatic Dosing:
- Adult: Prolonged clearance in cirrhosis
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Apnea
- Hypopnea
- Hypotension
- Delirium, when used for prolonged periods in ICU setting
Common
- Drowsiness
- Nausea/vomiting
Pharmacology
- Peak effect:
- IM: Children: 15 to 30 minutes; Adults: 30 to 60 minutes
- IV: 5 to 7 minutes
- Intranasal: 10 minutes
- Duration
- IV: Single dose: <2 hours (dose-dependent),up to 6 hours with cirrhosis
- IM: Up to 6 hours; Mean: 2 hours
- Intranasal: Children: 18 to 41 minutes
- Half-life: 1.8-6.4 hr
- Metabolism: Metabolized in liver by CYP3A4 to active metabolite α1-hydroxymidazolam
- Excretion: Renal
- Mechanism of Action: CNS depressant. Acts at GABA receptor to increase frequency of chloride channel opening, causing hyperpolarization and stabilization of neuronal membrane.
Indications by Condition
The following table is automatically generated from disease/condition pages across WikEM.
| Indication | Dose | Context | Route | Population |
|---|---|---|---|---|
| Agitated or combative patient | 5 mg IM | Benzodiazepine for agitation | IM | Adult |
| Excited delirium | 5 mg | Benzodiazepine sedation | IM | Adult |
| Procedural sedation | 1-2 mg | Procedural sedation (with fentanyl) | IV | Adult |
| Rapid sequence intubation | 0.2-0.3 mg/kg | Induction | IV | Adult |
| Status epilepticus (peds) | 0.2mg/kg IM/intranasal (max 10mg/dose) | Prehospital first-line for pediatric status epilepticus | IM/IN | Pediatric |
See Also
References
Micromedex